Trial intelligence / Profile preview

Norepinephrine versus phenylephrine infusion to prevent post-spinal hypotension during cesarean section

ChiCTR2200056237Phase 4Recruiting

Sponsor
Jiaxing Maternity and Child Health Care Hospital
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of norepinephrine and phenylephrine in hypotension (2 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: blood pressure. Started Feb 2022; status: recruiting.

02

Drugs

norepinephrinephenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2200056237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200056237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call